By continuing to use the site you agree to our Privacy & Cookies policy

Your browser seems to have cookies disabled. For the best experience of this website, please enable cookies in your browser.


Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


MRSA treatment 'may be more effective' if alternative drug used

The drug linezolid (Zyvox) may be more effective at treating patients with MRSA nosocomial pneumonia than the current gold standard vancomycin, according to trial results published in the journal Clinical Infectious Diseases.

Patients were randomized to receive intravenous linezolid (600 mg every 12 hours) or vancomycin (15 mg/kg every 12 hours) for up to two weeks.

Results showed 57.6% of 165 linezolid patients were cured, compared with 46.6% of 174 vancomycin patients.

However, there was no difference in mortality rates after 60 days and incidence of adverse events.

Have your say

You must sign in to make a comment.

Related Jobs

Sign in to see the latest jobs relevant to you!